Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sugammadex Compared With Neostigmin/Atropin for Neuromuscular Block Reversal in Patients With Obstructive Sleep Apnea

NCT02160223 is registered in ClinicalTrials.gov with Diskapi Teaching and Research Hospital as lead sponsor.

NCT NCT02160223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02160223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sugammadex Compared With Neostigmin/Atropin for Neuromuscular Block Reversal in Patients With Obstructive Sleep Apnea
Lead sponsor
Diskapi Teaching and Research Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2012
Completion date
June 30, 2014
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea